CIK 0001728328
- Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 604-669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- 4 Open-market buy 10% owner bought 42,920 shares at an average $1.33 ($57,080)
- 4 Open-market buy 10% owner bought 91,101 shares at an average $1.30 ($118,076)
- 4 Open-market buy 10% owner bought 1,000 shares at $1.56 ($1,555)
- 4 Open-market buy 10% owner bought 20,546 shares at $1.55 ($31,846)
- 4 Open-market buy 10% owner bought 6,551 shares at an average $1.55 ($10,148)
- 4 Open-market buy 10% owner bought 249,227 shares at an average $1.57 ($391,555)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 468,551 shares at an average $1.54 ($721,548)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 8 · 160 filings